Us Congress 2025-2026 Regular Session

Us Congress House Bill HB386

Introduced
1/14/25  
Refer
1/14/25  

Caption

Chinese Currency Accountability Act of 2025This bill requires the United States to oppose, absent specified conditions, any increase in the weight of Chinese currency (i.e., the renminbi) in the basket of currencies (currently, a set of five currencies, each with different weightings) used to determine the value of Special Drawing Rights. Special Drawing Rights are international reserve assets created by the International Monetary Fund (IMF) to supplement member countries' official foreign exchange reserves.Specifically, the Department of the Treasury must instruct certain U.S. officials at the IMF to oppose any such increase unless Treasury has certified that China is in compliance with certain standards and international agreements, including that (1) China is in compliance with all general obligations of members of the IMF, (2) China has not been found to have manipulated its currency in the preceding 12 months, and (3) China adheres to the rules and principles of the Paris Club and the Organisation for Economic Co-operation and Development (OECD) Arrangement on Officially Supported Export Credits. 

Impact

The enactment of HB386 would solidify the United States' position on currency valuation within the IMF framework and could lead to increased scrutiny of China's economic practices. It compels the Secretary of the Treasury to submit a report reflecting China's adherence to specific financial and ethical standards before any voting decisions are made regarding the renminbi’s weight in SDR. This condition underscores the U.S. commitment to transparency and compliance in international monetary policies, impacting how future negotiations within the IMF may unfold.

Summary

House Bill 386, titled the 'Chinese Currency Accountability Act of 2025', mandates that the United States' representatives at the International Monetary Fund (IMF) oppose any increase in the weight of the Chinese renminbi in the Special Drawing Rights (SDR) basket. The bill highlights concerns regarding China's compliance with international financial obligations, specifically aiming to prevent any recognition of the renminbi that could enhance its influence in global finance without clear regulatory compliance. This legislative action reflects a broader strategy to monitor and manage China's economic weight on the international stage.

Sentiment

The sentiment surrounding HB386 appears to be cautious yet proactive among lawmakers, reflecting bipartisan support for accountability in China's currency practices. Proponents argue that the move is essential to protect the integrity of global finance and curb any potential imbalances favoring China's economic ascendancy. Critics, however, may view the bill as a politically motivated stance that does not necessarily address broader trade relations or the complexities of international finance but rather emphasizes the tensions between the U.S. and China.

Contention

Notable points of contention highlight the balance between supporting international financial frameworks and preventing perceived currency manipulation by China. Some legislators express concerns that overly aggressive measures might exacerbate trade tensions or provoke retaliatory actions from Beijing. Moreover, the sunset provision indicating that the bill will lose its effectiveness after ten years raises questions regarding the long-term strategy and sustainability of U.S. currency policies, further igniting debate among financial experts and policymakers.

Congress_id

119-HR-386

Policy_area

Foreign Trade and International Finance

Introduced_date

2025-01-14

Companion Bills

No companion bills found.

Previously Filed As

US HB510

Chinese Currency Accountability Act of 2023

US SB1919

Chinese Currency Accountability Act of 2023

US HB499

Securing American Families and Enterprises from People's Republic of China Investments Act or the SAFE from PRC Investments Act This bill requires certain issuers of securities and funds traded on an exchange to report on connections to China or the Communist Party of China. In particular, an issuer with specified connections to China must annually disclose a variety of details, including whether executive-level employees, senior directors, or board members are members of the Communist Party of China; interactions with the party; expenditures in China; expenditures in the United States regarding operations and lobbying activities; and the ability of the Public Company Accounting Oversight Board to audit the issuer. Additionally, an exchange-traded fund that invests in a Chinese company must annually disclose about that company ownership information, party involvement, whether the company participates in specified Chinese policies or activities, any ties to U.S.-sanctioned individuals, and the types of products or services produced by the company.

US HB229

World Deserves To Know Act This bill requires sanctions on certain members of the Chinese Communist Party (CCP) and officials of Chinese health agencies. It also addresses related issues. The President must impose visa- and property-blocking sanctions on any foreign person who is a CCP official and who is knowingly responsible for or complicit in (1) the disappearances of whistleblowers and citizen journalists in China relating to COVID-19, or (2) limiting free speech and academic freedom in China relating to COVID-19. The President must also impose such sanctions on specified individuals who have leadership positions in China's Center for Disease Control and Prevention and China's National Health Commission (NHC). The authority to impose such sanctions shall end when the President certifies to Congress that an independent and unimpeded investigation into the potential origin of COVID-19 from the Wuhan Institute of Virology has taken place. The bill also bars federal funds and certain federal student assistance from going to institutions of higher education that enter into a contract with any element or China-based affiliate of the NHC. Federal funding to the National Academy of Sciences may not be used to enter into a contract with any element or China-based affiliate of the NHC. The Government Accountability Office must report to Congress a review of all funds that the National Institutes of Health have made available to the NHC since FY2010. This report must also be publicly available.

US HB222

No Oil for CCP Act This bill bans exports of crude oil from the Strategic Petroleum Reserve (SPR) to China, North Korea, Iran, and other specified recipients. Specifically, the bill directs the Department of Energy to require as a condition of any sale of crude oil from the SPR that (1) the oil not be exported to such countries; and (2) the recipient of the oil is not under the ownership, control, or influence of the Chinese Communist Party.

US SR460

A resolution supporting the United States dollar as the reserve currency of the world and combating the economic influence of the People's Republic of China.

US HR1069

Demanding that the Government of the People's Republic of China and the Chinese Communist Party immediately release Kai Li.

US HB22

Protecting America's Strategic Petroleum Reserve from China Act This bill prohibits the sale and export of crude oil from the Strategic Petroleum Reserve (SPR) to China. Specifically, the bill prohibits the Department of Energy (DOE) from selling petroleum products (e.g., crude oil) from the SPR to any entity that is under the ownership, control, or influence of the Chinese Communist Party. Further, DOE must require as a condition of any sale of crude oil from the SPR that the oil not be exported to China.

US HB8394

To restrict the Chinese Government from accessing United States capital markets and exchanges if it fails to comply with international laws relating to finance, trade, and commerce.

US SB3945

A bill to restrict the Chinese Government from accessing United States capital markets and exchanges if it fails to comply with international laws relating to finance, trade, and commerce.

Similar Bills

No similar bills found.